EUVIMEDEUVIMED entdecken
Open Access

A simple MRI / PET ‐derived index predicts relapse‐free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer

Ikuma Shioi iD, Takuya Shiraishi iD, Kosei Uehara iD, Yutaro Shimizu, Nobuhiro Hosoi, Gendensuren Dorjkhorloo, Chika Katayama, Yuta Shibasaki, Chika Komine, Takuhisa Okada, Akiharu Kimura iD, Akihiko Sano iD und 4 weitere

Colorectal Disease · 2026-08 · 28 (8)

DOI: 10.1111/codi.70560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Colorectal Disease, online erschienen am 23.07.2026. Verfasst von Ikuma Shioi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan. Hauptthemen laut MEDLINE: Rectal Neoplasms, Neoadjuvant Therapy, Magnetic Resonance Imaging, Positron Emission Tomography Computed Tomography. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Reliable pretreatment biomarkers for predicting resistance to standard chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC) remain lacking. This study evaluated the prognostic value of the tumour area (TA)‐to‐maximum standardized uptake value (SUVmax) [T/S] ratio, a novel imaging index derived from magnetic resonance imaging (MRI) and 18 F‐fluorodeoxyglucose positron emission tomography‐computed tomography (PET‐CT), for predicting oncological outcomes in LARC.

Method

We retrospectively analysed 68 patients with LARC who underwent preoperative CRT followed by curative resection between 2013 and 2024. TA was measured on axial T2‐weighted MRI, and SUVmax was obtained from PET‐CT. The T/S ratio was calculated as TA/SUVmax. Receiver operating characteristic analysis determined the optimal cut‐off for relapse‐free survival (RFS). Cox proportional hazards models identified independent prognostic factors. Immunohistochemical analysis of L‐type amino acid transporter 1 (LAT1) was performed in 33 patients without CRT to explore biological relevance.

Results

The T/S ratio showed superior predictive accuracy for RFS (area under the curve, 0.714) than for TA (0.616) and SUVmax (0.574). Patients with a high T/S ratio (cut‐off 55.81) demonstrated significantly poorer 3‐year RFS (51.8% vs. 84.0%, p = 0.002). Multivariate analysis confirmed high T/S ratio as an independent RFS predictor ( HR 4.59; 95% CI: 1.27–16.55; p = 0.019). Tumours with high T/S ratios tended to exhibit elevated LAT1 expression, potentially reflecting a CRT ‐resistant phenotype.

Conclusions

The pretreatment T/S ratio is a simple, noninvasive biomarker that independently predicts RFS in patients with LARC undergoing CRT. This index may assist in risk stratification and individualized neoadjuvant strategy selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsNeoadjuvant TherapyMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyChemoradiotherapyHumansRetrospective StudiesFemaleMaleDisease-Free SurvivalPrognosisMiddle AgedAgedFluorodeoxyglucose F18Predictive Value of TestsRadiopharmaceuticalsNeoplasm Recurrence, LocalChemoradiotherapy, AdjuvantROC CurveAdult

Stichwörter der Autor:innen

18F‐FDG PET‐CTchemoradiotherapylocally advanced rectal cancermagnetic resonance imagingrelapse‐free survival

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
  • Division of Integrated Oncology Research, Gunma University, Initiative for Advanced Research (GIAR), Maebashi, Gunma, Japan.

ORCID-Profile: Ikuma Shioi, Takuya Shiraishi, Kosei Uehara, Akiharu Kimura, Akihiko Sano, Makoto Sakai, Ken Shirabe

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Shioi, I., Shiraishi, T., Uehara, K., Shimizu, Y., Hosoi, N., Dorjkhorloo, G., Katayama, C., Shibasaki, Y., Komine, C., Okada, T., Kimura, A., Sano, A., Yokobori, T., Sakai, M., Shirabe, K., & Saeki, H. (2026). A simple MRI / PET ‐derived index predicts relapse‐free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Colorectal Disease, 28(8). https://doi.org/10.1111/codi.70560

Vancouver

Shioi I, Shiraishi T, Uehara K, Shimizu Y, Hosoi N, Dorjkhorloo G, et al. A simple MRI / PET ‐derived index predicts relapse‐free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Colorectal Disease. 2026;28(8). doi:10.1111/codi.70560

BibTeX
@article{Shioi2026,
  author = {Shioi, Ikuma and Shiraishi, Takuya and Uehara, Kosei and Shimizu, Yutaro and Hosoi, Nobuhiro and Dorjkhorloo, Gendensuren and Katayama, Chika and Shibasaki, Yuta and Komine, Chika and Okada, Takuhisa and Kimura, Akiharu and Sano, Akihiko and Yokobori, Takehiko and Sakai, Makoto and Shirabe, Ken and Saeki, Hiroshi},
  title = {A simple MRI / PET ‐derived index predicts relapse‐free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer},
  journal = {Colorectal Disease},
  year = {2026},
  volume = {28},
  number = {8},
  doi = {10.1111/codi.70560}
}
Kostenlos starten →